W W Jedrzejczak Selected Research

Daunorubicin (Cerubidine)

5/2004

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W W Jedrzejczak Research Topics

Disease

2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2013 - 11/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2005 - 05/2004
1	Human Adenovirus Infections 01/2012
1	Hematologic Diseases (Blood Diseases) 11/2007
1	Stomatitis 11/2007
1	Leukemia 12/2005
1	Hodgkin Disease (Hodgkin's Disease) 06/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2004
1	Hypoalbuminemia 01/2001

Drug/Important Bio-Agent (IBA)

2	Cladribine FDA LinkGeneric 12/2005 - 05/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2013
1	Fibroblast Growth Factor 7 FDA Link 11/2007
1	Daunorubicin (Cerubidine)FDA LinkGeneric 05/2004
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2004
1	AlbuminsIBA 01/2001

Therapy/Procedure

1	Hematopoietic Stem Cell Transplantation 01/2012
1	Autologous Transplantation 12/2005
1	Therapeutics 06/2004
1	Drug Therapy (Chemotherapy) 06/2004
1	Stem Cell Transplantation 06/2004